[4-(6-methylpyrazin-2-yl)piperidin-1-yl]-(1-methylpyrazol-3-yl)methanone

C15H19N5O — CID 95845578

IUPAC[4-(6-methylpyrazin-2-yl)piperidin-1-yl]-(1-methylpyrazol-3-yl)methanone
SMILESCc1cncc(C2CCN(C(=O)c3ccn(C)n3)CC2)n1
InChIInChI=1S/C15H19N5O/c1-11-9-16-10-14(17-11)12-3-7-20(8-4-12)15(21)13-5-6-19(2)18-13/h5-6,9-10,12H,3-4,7-8H2,1-2H3
InChIKeyWEOOMWUZKUVNJR-UHFFFAOYSA-N
MW285.35 g/mol
LogP1.54
Rot. Bonds2

About [4-(6-methylpyrazin-2-yl)piperidin-1-yl]-(1-methylpyrazol-3-yl)methanone

[4-(6-methylpyrazin-2-yl)piperidin-1-yl]-(1-methylpyrazol-3-yl)methanone (PubChem CID 95845578) has the molecular formula C15H19N5O and a molecular weight of 285.35 g/mol. Its IUPAC name is [4-(6-methylpyrazin-2-yl)piperidin-1-yl]-(1-methylpyrazol-3-yl)methanone.

Molecular Properties

Compound Name[4-(6-methylpyrazin-2-yl)piperidin-1-yl]-(1-methylpyrazol-3-yl)methanone
PubChem CID95845578
Molecular FormulaC15H19N5O
Molecular Weight285.35 g/mol
Exact Mass285.16
IUPAC Name[4-(6-methylpyrazin-2-yl)piperidin-1-yl]-(1-methylpyrazol-3-yl)methanone
SMILESCc1cncc(C2CCN(C(=O)c3ccn(C)n3)CC2)n1
InChIInChI=1S/C15H19N5O/c1-11-9-16-10-14(17-11)12-3-7-20(8-4-12)15(21)13-5-6-19(2)18-13/h5-6,9-10,12H,3-4,7-8H2,1-2H3
InChIKeyWEOOMWUZKUVNJR-UHFFFAOYSA-N
XLogP1.54
TPSA63.91 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds2
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500285.35
LogP ≤ 51.54
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Analyze [4-(6-methylpyrazin-2-yl)piperidin-1-yl]-(1-methylpyrazol-3-yl)methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(1-methylpyrazol-3-yl)-[4-(6-methyl-2-pyridinyl)piperidin-1-yl]methanone
CID 95824434
(1-methylpyrazol-3-yl)-(4-pyrazin-2-ylpiperidin-1-yl)methanone
CID 95824432
[4-[4-(dimethylamino)-6-methyl-2-pyridinyl]piperidin-1-yl]-(1-methylpyrazol-3-yl)methanone
CID 95828652
[4-(6-methylpyrazin-2-yl)piperidin-1-yl]-(2-methylpyrazol-3-yl)methanone
CID 95845680
[4-(6-methylpyrazin-2-yl)piperidin-1-yl]-(1,3-oxazol-5-yl)methanone
CID 95846134
[4-(6-methylpyrazin-2-yl)piperidin-1-yl]-(3-methyl-2-pyridinyl)methanone
CID 124970955
1,3-benzodioxol-5-yl-[4-(6-methylpyrazin-2-yl)piperidin-1-yl]methanone
CID 124985003
[4-(aminomethyl)piperidin-1-yl]-(1-methylpyrazol-3-yl)methanone
CID 103115889
(4-methylpiperazin-1-yl)-(1-methylpyrazol-3-yl)methanone
CID 2172453
(1-methylpyrazol-3-yl)-piperidin-1-ylmethanone
CID 19577577
(3-methylazetidin-1-yl)-(1-methylpyrazol-3-yl)methanone
CID 123809651
1-[2-[4-(6-methylpyrazin-2-yl)piperidine-1-carbonyl]pyrrolidin-1-yl]ethanone
CID 127246223

Frequently Asked Questions

What is the IUPAC name of [4-(6-methylpyrazin-2-yl)piperidin-1-yl]-(1-methylpyrazol-3-yl)methanone?
The IUPAC name of [4-(6-methylpyrazin-2-yl)piperidin-1-yl]-(1-methylpyrazol-3-yl)methanone (CID 95845578) is [4-(6-methylpyrazin-2-yl)piperidin-1-yl]-(1-methylpyrazol-3-yl)methanone.
What is the SMILES notation for [4-(6-methylpyrazin-2-yl)piperidin-1-yl]-(1-methylpyrazol-3-yl)methanone?
The canonical SMILES for [4-(6-methylpyrazin-2-yl)piperidin-1-yl]-(1-methylpyrazol-3-yl)methanone is Cc1cncc(C2CCN(C(=O)c3ccn(C)n3)CC2)n1.
What is the InChIKey of [4-(6-methylpyrazin-2-yl)piperidin-1-yl]-(1-methylpyrazol-3-yl)methanone?
The InChIKey is WEOOMWUZKUVNJR-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H19N5O/c1-11-9-16-10-14(17-11)12-3-7-20(8-4-12)15(21)13-5-6-19(2)18-13/h5-6,9-10,12H,3-4,7-8H2,1-2H3.
What are the key properties of [4-(6-methylpyrazin-2-yl)piperidin-1-yl]-(1-methylpyrazol-3-yl)methanone?
[4-(6-methylpyrazin-2-yl)piperidin-1-yl]-(1-methylpyrazol-3-yl)methanone has a molecular weight of 285.35 g/mol, XLogP of 1.54, 2 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [4-(6-methylpyrazin-2-yl)piperidin-1-yl]-(1-methylpyrazol-3-yl)methanone is sourced from PubChem (CID 95845578), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).